Promoters held 63.85 per cent stake in the company as of 30-Jun-2022, while FIIs owned 14.16 per cent, DIIs 13.71 per cent.

“I keep looking at the markets and we keep looking at stocks where the market feels there is no growth left in the stock and if we see the kind of growth, we will go ahead and buy like we bought Thomas Cook. We bought hotel stocks about a couple of years back. We will keep looking at these things and buy and then hold on.”

Narayana Hrudayalaya, incorporated in the year 2000, is a Mid Cap company (having a market cap of Rs 15467.05 Crore) operating in Hospitals & Allied Services sector.

Prabhudas Lilladher is bullish on Narayana Hrudayalaya has recommended buy rating on the stock with a target price of Rs 920 in its research report dated December 19, 2022.

ICICI Direct is bullish on Narayana Hrudayalaya recommended buy rating on the stock with a target price of Rs 855 in its research report dated November 12, 2022.

Nifty has formed a bearish candle with a gap but has managed to close above 18,000 level. Broad based indices Nifty 500 indicates slight gloomy over bulls as 127 stocks advanced while 373 declined

“This is the best ever I have seen in the banking sector for the last 25-30 years or so, where credit growth is moving up and that is leading to higher net interest income. Fee-based income is also coming through strongly because of new loans which they have approved. At the same time, credit costs are flat to declining and this is a blue sky scenario for banks.”

Despite the challenging environment, the company has leveraged its large-scale hospitals with world-class infrastructure, high-end medical equipment and technology to record decent operational and financial performance, said Reliance Securities.

The acquisition will enable HCCI to expand its healthcare business in Cayman Island into ENT specialty, the hospital chain said in a regulatory filing

The discount to KIMS has been assigned in comparison to the aforementioned peers on the back of high concentration risk with around 2/3rd of the companys sales being accounted for by Hyderabad and higher execution risks given the investment phase lined up over the next few years.

“We are seeing a decent amount of interest coming through in almost every sector with the exception of perhaps commodities and software companies where the earnings may be slightly on the softer side. But by and large, we should see a very good earning season. That is driving a lot of interest into stocks. ”

Prabhudas Lilladher is bullish on Narayana Hrudayalaya has recommended buy rating on the stock with a target price of Rs 810 in its research report dated September 06, 2022.

Narayana Hrudayalaya Ltd., incorporated in the year 2000, is a Mid Cap company (having a market cap of Rs 14609.75 Crore) operating in Hospitals & Allied Services sector.

The Hyderabad-based startup has partnered with more than 50 hospitals and is looking to expand to over 15 cities in India by the end of this year.

Prabhudas Lilladher is bullish on Narayana Hrudayalaya has recommended buy rating on the stock with a target price of Rs 810 in its research report dated August 12, 2022.

ICICI Direct is bullish on Narayana Hrudayalaya has recommended buy rating on the stock with a target price of Rs 800 in its research report dated August 12, 2022.

Net Sales are expected to increase by 15.4 percent Y-o-Y (up 5.5 percent Q-o-Q) to Rs. 992.1 crore, according to ICICI Direct.

His government has now lobbed the ball into Tamil Nadus court. Bangalore Metro Rail Corporation (BMRCL) managing director Anjum Parwez has written to the union housing & urban affairs ministry, conveying that the TN government could take up the study on linking Bommasandra in Bengaluru.

ICICI Direct is bullish on Narayana Hrudayalaya has recommended buy rating on the stock with a target price of Rs 750 in its research report dated May 24, 2022.

Prabhudas Lilladher is bullish on Narayana Hrudayalaya has recommended buy rating on the stock with a target price of Rs 773 in its research report dated May 24, 2022.

NTPC, One97 Communications, Zydus Lifesciences, IRFC, Thermax, Pfizer, Metro Brands and Narayana Hrudayalaya are among companies which will announce their quarterly earnings today.

NTPC, Thermax, Paytm, Zydus Lifesciences, Indigo Paints, IRFC, Pfizer, Metro Brands, Narayana Hrudayalaya, Nuvoco Vistas, Sobha, IDFC, Amaja Raja Batteries and CE Info Systems are among the companies which will announce their earnings today.

Net Sales are expected to increase by 13.5 percent Y-o-Y (down 0.9 percent Q-o-Q) to Rs. 951.2 crore, according to ICICI Direct.

Speaking at an industry event here, Shetty noted that with digital aid, people from all strata of society and even from the remotest locations across the country can reach out to top physicians in the country for consultation, which was not the case earlier.

The hospital chain reported a 57 per cent jump in revenue to Rs 940.28 crore in the quarter ended September 2021 as against Rs 600.73 crore during the previous year quarter.